Renovaro Biosciences
RENB
#8772
Rank
$0.10 B
Marketcap
$0.63
Share price
2.09%
Change (1 day)
-79.88%
Change (1 year)

Earnings for Renovaro Biosciences (RENB)

Earnings in 2024 (TTM): -$0.12 Billion USD

According to Renovaro Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$41.24 Million USD, an increase over its 2022 earnings that were of -$0.11 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Renovaro Biosciences from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.12 Billion178.53%
2023 -$41.24 Million-62.03%
2022 -$0.11 Billion182.88%
2021 -$38.39 Million246.9%
2020 -$11.07 Million614.13%
2019 -$1.55 Million-93.65%
2018 -$24.42 Million1119.78%
2017 -$2.01 Million-29.21%
2016 -$2.83 Million
2014 -$2.57 Million6701.79%
2013 -$0.04 Million16.61%
2012 -$0.04 Million